Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 20 Biotech Startup Investors in Estonia in January 2026

Last updated: Jan 2026 A list of 20 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Estonia. We rank investors based on the number of investments they made in Biotech companies from Estonia. We update this investor list every month.

Top 20 Biotech Startup Investors in Estonia in January 2026

Investor	Biotech Estonia investments
Prototron	3
Enterprise Estonia	3
Nordic Foodtech VC	2
Voima Ventures	2
Domain Associates	1
Crosslight Partners	1
AS AMALFI	1
Change Ventures	1
Specialist VC	1
Johanna Britt Berzin	1
Estonian Research Council	1
Robert Laud	1
Peep Vain	1
Grid.vc	1
European Investment Bank	1
Ivo Remmelg	1
Johnson & Johnson Development Corporation	1
Hugues Flament	1
Timo Rein	1
Siim Sikkut	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Prototron is a start-up fund that gives money to teams for turning their great ideas into the first working prototype. Founded in 2012 by Swedbank, Tallinn Technical University and Tallinn Science Park Tehnopol. We finance teams with high growth potential in areas of Greentech, Electronics, Mechatronics and ICT. We run 3-4 rounds of financingevery year. During last 5 years we've funded 58 startups with over 470'000€ in cash + coaching/incubation services. Our protfolio has generated >4,5 M€ revenue and raised >17'000'000€ capital. These results make Prototron the most productive pre-seed fund in Estonia. Do you want to be part of the success? We seek for: *) New start-up teams who need money for building a prototype. Apply for funding: www.prototron.ee *) Additional partners who want to be part of Estonia's next success stories.

Investment focus

Software, Manufacturing, Internet of Things
Pre-Seed, Grant, Seed
Estonia, Finland, Germany

Portfolio highlights

Neurosalience — Neurosalience develops a tool for the early detection of dementia from structural MRI scans.
RAIKU — RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm tonature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.
Jälle Technologies — Jälle Technologies create advanced recycling technologies that transform battery waste into high-value resources.

Enterprise Estonia (EAS), established in 2000, promotes business and regional development in Estonia. Enterprise Estonia is one of the largest institutions within the national support system for entrepreneurship, providing financial assistance, advisory, cooperation opportunities and training for entrepreneurs, research establishments, public andthird sector.

Investment focus

Biotechnology, Software, Mobile Apps
Grant, Seed, Pre-Seed
Estonia

Portfolio highlights

MYCEEN — MYCEEN is a carbon-negative materials combining mushroom mycelium and industrial byproducts.
Lifeyear — Digital-first heart care. At scale.
Jälle Technologies — Jälle Technologies create advanced recycling technologies that transform battery waste into high-value resources.

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

Investment focus

Biotechnology, Life Science, Water
Seed, Series A, Funding Round
Finland, Sweden, Denmark

Portfolio highlights

EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Investment focus

Biotechnology, Health Care, Artificial Intelligence
Seed, Pre-Seed, Funding Round
Finland, Sweden, Norway

Portfolio highlights

Farang — Farang is an AI research lab based in Sweden developing the next-generation of foundational Large Language Models. The company was founded in 2025 and consists of a team of highly experienced researchers, developers, entrepreneurs and business professionals, joined by prominent deep-tech VCs and angel investors.
Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.

INVESTMENT ADVISORS TO THE FIRST VC FUND DEDICATED TO BIOTECH INVESTMENT MANAGER OF 9 SUBSEQUENT BIOTECH VC FUNDS

Investment focus

Biotechnology, Health Care, Medical
Series B, Series C, Series A
United States, Canada, Estonia

Portfolio highlights

Epic Sciences — Epic Sciences develops clinical solutions that accelerate drug development and guided therapy across cancer drug indications. Epic's new AR-V7 CTC liquid biopsy test is the first clinically proven predictive test for metastatic castration-resistant prostate cancer.
Antios Therapeutics — This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I'm a bike messenger
Fractyl Health — Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.

Crosslight Partners is a growth equity firm. The firm invests in the environment, healthcare, impact, and technology sectors across Europe.

Investment focus

Biotechnology, B2B, Medical
Seed, Funding Round
Sweden, Estonia

Portfolio highlights

Gelatex Technologies — Gelatex is a Techstars-backed materials technology company that invented the fastest technology for producing bio-based nanofibers on a large scale. It is a platform technology that enables faster and up to 100 cheaper nanofiber production for applications like 3D scaffolds for tissue engineering, cultured meat, bio-based filters, eco-friendlyleather-like textile, energy storage, wound care, and many more. The technology is patent-pending and the machinery fully functional. The company was founded in 2016 and until COVID-19 pandemic developed eco-friendly leather-like textile from gelatin nanofibers, using this nanofiber production technology as part of the process. COVID-19 was a trigger to understand the wider potential of the technology which then led to pivot.The company is based in Estonia and holding incorporated in UK (2019).
Sigrid Therapeutics — Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.

AS AMALFI

Investment focus

Biotechnology
Pre-Seed
Estonia

Portfolio highlights

Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

We are a seed stage venture capital fund based in the Baltic states, backing ambitious Baltic founders anywhere in the world.

Investment focus

Software, Information Technology, Apps
Seed, Pre-Seed, Series A
Estonia, Latvia, Lithuania

Portfolio highlights

Eurora — Eurora develops an e-commerce suite of customs compliance tools.
FanSifter — FanSifter is a fan data management platform that leverages machine learning to help rights holders in music, entertainment, and sports increase tickets, music, merch, experiences, and sponsorships sales.
RecruitLab — Teamdash's built-in recruitment, applicant tracking, and marketing features give you the focus you need to achieve the impossible. Here's how.

United Angels VC is an early stage venture capital fund based in Estonia.

Investment focus

Information Technology, Software, Artificial Intelligence
Seed, Pre-Seed, Funding Round
Estonia, United Kingdom, Finland

Portfolio highlights

Sera — Sera's AI streamlines prospecting with tailored lists and enriched profiles, including accurate emails and metrics.
Vocal Image — Join 4M+ Vocal Image users to improve your communication skills in just minutes. Discover your voice type, boost confidence & speak better. Try now.
Better Medicine — Utilising AI to transform cancer diagnostics and radiology workflows for improved efficiency and patient outcomes.

Johanna Britt Berzin

Investment focus

Biotechnology
Pre-Seed
Estonia

Portfolio highlights

Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

We support research and innovation in Estonia: provide research funding, R&D analysis, input for better policy-making and science communication activities.

Investment focus

Biotechnology
Seed
Estonia

Portfolio highlights

MYCEEN — MYCEEN is a carbon-negative materials combining mushroom mycelium and industrial byproducts.

Robert Laud

Investment focus

Biotechnology
Pre-Seed
Estonia

Portfolio highlights

Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

Peep Vain is the Private Investor at Vain and Partners. He attended Bentley University.

Investment focus

Software, Genetics, Recruiting
Seed, Angel
Estonia

Portfolio highlights

Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
Bisly — Bisly Scalable Building Automation reduces the overhead for building professionals and makes energy saving easy and affordable.
Bidrento — One powerful platform for your entire portfolio. The leading property and tenant management software. Scale your operations and maximize your profit with Bidrento. Try it already today!

Grid.vc is the first investor in superb teams disrupting the energy business.

Investment focus

Energy, Renewable Energy, SaaS
Seed, Pre-Seed, Funding Round
Finland, Estonia

Portfolio highlights

Bioreactor — Bioreactor is a revolutionary technology that converts bio waste into clean energy through biomass gasification. It's a sustainable, efficient and cost-effective solution that addresses energy poverty, energy security and climate change. With the use of the latest technology in computational fluid dynamics, cloud-optimized digital twin anddeep learning algorithms, the Bioreactor can optimize its performance in real-time over a wide range of fuels and operating conditions. The Bioreactor is a game changer in the energy industry, it can reduce greenhouse gas emissions, drastically lower energy costs, and help to alleviate energy poverty on a national scale.
Safegrid — Smarter sensors for a smarter grid
Vensum Power — Revolutionizing power conversion. More power in same package, less energy waste and low maintenance.

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Investment focus

Biotechnology, Health Care, Energy
Debt Financing, Post-IPO Debt, Funding Round
France, Germany, The Netherlands

Portfolio highlights

Solynta — Welcome to the homepage of Solynta, leader in hybrid potato breeding and development of hybrid true potato seeds with attractive traits.
Evaxion Biotech — Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currentlyincludes three patient-specific cancer immunotherapies, two of which are in Phase I/IIa clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections with one program currently in preclinical development against S. aureus (including Methicillin-resistant S. aureus) induced skin and soft tissue infections.
Electrica — Electrica is a holding company involved in projects connected to the provision of power to final consumers as well as the development and operation of electrical distribution networks. It primarily serves as the principal electricity supplier in and throughout the town as well as an electricity distribution operator. The following segments make upthe company's business: electricity and gas supply, which is involved in acquiring and providing electricity and gas to end users, electricity generation, which produces electricity, electricity distribution, which offers services related to electricity distribution, external electricity network services, which provides maintenance, repairs, and other services for electricity networks owned by other distributors, and electricity distribution.

Ivo Remmelg is a Venture Partner at Superhero Capital and the Founding Partner of NestCap.

Investment focus

Mobile, Sports, Software
Seed, Angel, Pre-Seed
Estonia, Norway

Portfolio highlights

Sportlyzer — Sportlyzer is a player development and team management software for youth and amateur sports clubs. The platform connects coaches, managers, players and parents.
Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
Nordic Automation Systems — Full vertical LPWAN solution provider with flexible in-house R&D and production to enable fast roll out to the market.

JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.

Investment focus

Health Care, Biotechnology, Medical
Series C, Series B, Funding Round
United States, United Kingdom, Canada

Portfolio highlights

Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
Prana Thoracic — A minimally invasive, lung-sparing device that will provide physicians and patients with the certainty they need to move forward with treatment.
Osteal Therapeutics — Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.

Hugues Flament

Investment focus

Biotechnology
Pre-Seed
Estonia

Portfolio highlights

Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

Timo Rein - Co-Founder @ Pipedrive

Investment focus

Software, Artificial Intelligence, Human Resources
Seed, Angel, Convertible Note
Estonia, Finland, United Kingdom

Portfolio highlights

YuMuuv — YuMuuv is an employee wellness platform that uses science-based formulas to capture data and keeps track of physical activity & leaderboard.
Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
Bidrento — One powerful platform for your entire portfolio. The leading property and tenant management software. Scale your operations and maximize your profit with Bidrento. Try it already today!